Chevy Chase Trust
IART icon

Chevy Chase Trust’s Integra LifeSciences IART Stock Holding History

Chevy Chase Trust’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-352
Closed -$21K – 794
2019
Q4 		$21K Buy
+352
New +$21K ﹤0.01% 989

Other funds holding IART

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Chevy Chase Trust's IART Position: Q1 2020 in Review

Chevy Chase Trust sold out of Integra LifeSciences (IART) in Q1 2020, closing a stake of 352 shares — an estimated $21K sold.

Chevy Chase Trust first reported a position in IART in Q4 2019 and held it in 1 quarter. The position peaked at $21K in Q4 2019. 258 funds tracked by Wall St. Rank hold IART as of Q1 2020.

  • Chevy Chase Trust reported no remaining Integra LifeSciences position as of Q1 2020 after selling out during the quarter.
  • Chevy Chase Trust sold 352 Integra LifeSciences shares in Q1 2020, an estimated $21K.
  • Chevy Chase Trust first reported a position in Integra LifeSciences in Q4 2019 and held it in 1 quarter.
  • Chevy Chase Trust's Integra LifeSciences position peaked at $21K in Q4 2019.
  • 258 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2020.

Based on Chevy Chase Trust's 13F filing for Q1 2020, filed 13 May 2020.